CureVac (CVAC)
(Delayed Data from NSDQ)
$3.68 USD
-0.11 (-2.90%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $3.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
CVAC 3.68 -0.11(-2.90%)
Will CVAC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CVAC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CVAC
CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
CVAC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Other News for CVAC
Agomab Bolsters Executive Team with Appointment of Pierre Kemula as Chief Financial Officer
Quest Diagnostics, Southwest Airlines rise; Simulations Plus falls, Wednesday, 7/3/2024
TOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugs
CureVac Shareholders Approve Key Resolutions
Bird flu shots to begin in Finland